SOMNF (SomnoMed) Common Stock: $74.55 Mil (As of Dec. 2025)


SOMNF SomnoMed Ltd SOMNF
49 GF Score
Price $0.45
GF Value $0.32
Valuation Significantly Overvalued
! 3 Warning Signs
View Full Analysis

What is SomnoMed Common Stock?

SomnoMed SOMNF 49 Common Stock is $74.55 Mil as of Dec. 2025. GuruFocus rates SOMNF with a GF Score™ of 49/100 and a GF Value™ of $0.32 (Significantly Overvalued). The stock has 3 warning signs investors should review.

SomnoMed's quarterly common stock increased from Dec. 2024 ($69.81 Mil) to Jun. 2025 ($71.77 Mil) and increased from Jun. 2025 ($71.77 Mil) to Dec. 2025 ($74.55 Mil).

SomnoMed's annual common stock increased from Jun. 2023 ($49.85 Mil) to Jun. 2024 ($73.20 Mil) but then declined from Jun. 2024 ($73.20 Mil) to Jun. 2025 ($71.77 Mil).

SomnoMed Common Stock Historical Data

* Premium members only.

The historical data trend for SomnoMed's Common Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

SomnoMed Common Stock Chart

SomnoMed Annual Data
Trend Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24 Jun25
Common Stock
Get a 7-Day Free Trial Premium Member Only Premium Member Only 56.77 52.19 49.85 73.20 71.77

SomnoMed Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Common Stock Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 59.47 73.20 69.81 71.77 74.55
SOMNF
49GF Score
SomnoMed Ltd SOMNF
Common Stock is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

SomnoMed Common Stock Calculation

Common stock is listed on the Balance Sheet at the par value of the total shares outstanding of a company.

The par value of common stocks is meaningless. It is usually set at an absurdly low number.

Frequently Asked Questions Learn more about Common Stock →
What does a Common Stock of $74.55 Mil mean?
SomnoMed (SOMNF) has a Common Stock of $74.55 Mil as of Dec. 2025. Common Stock is the par value of a company's shares outstanding, as listed on the balance sheet. View historical data on SomnoMed and its competitors.
Is SomnoMed's Common Stock too high?
SomnoMed's current Common Stock is $74.55 Mil. Overall, SomnoMed has a GF Score™ of 49/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does SomnoMed's Common Stock compare to ABT and SYK?
SomnoMed's Common Stock of $74.55 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Common Stock for a Medical Devices & Instruments company?
A good Common Stock depends on the Medical Devices & Instruments industry context. However, Common Stock should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Common Stock mean?
A high Common Stock can signal that a stock is expensive relative to its fundamentals. Common Stock is the par value of a company's shares outstanding, as listed on the balance sheet. View historical data on SomnoMed and its competitors. SomnoMed's current Common Stock is $74.55 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is SomnoMed stock overvalued right now?
Based on GuruFocus' analysis, SomnoMed (SOMNF) is currently considered Significantly Overvalued. The stock's GF Value™ is $0.32, compared to a current price of $0.45 — trading 40% above its estimated fair value. The current Common Stock is $74.55 Mil. SomnoMed's overall GF Score™ is 49/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Common Stock calculated?
Common Stock is calculated from a company's financial statements. For SomnoMed (SOMNF), the current Common Stock is $74.55 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is SomnoMed (SOMNF) Overvalued in 2026?

Based on GuruFocus' analysis, SomnoMed stock appears to be overvalued. The current stock price of $0.45 is trading 40% above its estimated GF Value™ of $0.32. GuruFocus considers SomnoMed to be Significantly Overvalued.

Key valuation signals for SOMNF:

  • Common Stock: $74.55 Mil
  • GF Value™: $0.32 vs. price of $0.45 (40% above fair value)
  • GF Score™: 49/100 with 3 warning signs

No single metric tells the full story. See the SOMNF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

SomnoMed Business Description

Other Exchanges RJV:GermanySOM:Australia
Address 20 Clarke Street, Level 3, Crows Nest, Sydney, NSW, AUS, 2065
SomnoMed Ltd provides treatment solutions for sleep-related breathing disorders, including obstructive sleep apnea, snoring, and bruxism. It is engaged in commercializing SomnoDent Mandibular Advancement Splint (MAS) and other oral devices for sleep-related disorders in Australia and overseas. The other products in the company's portfolio include SomMorning Repositioner; SomnoBrux splint, a custom-fit, acrylic splint (dental guard) for upper teeth designed to protect teeth from grinding and scraping during Bruxism; and SomTabs cleaning tablets that have been developed to clean oral appliances. Geographically, the company generates maximum revenue from Europe, followed by North America and the Asia Pacific region.
49GF Score

Get the complete analysis for SOMNF

Common Stock is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.45
Price
$0.32
GF Value